Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Porto Biomedical Journal|April 19, 2021
Impact of montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19): protocol for an investigator-initiated open labeled randomized controlled pragmatic trialMargarida Tavares, Mariana Farraia, Susana Silva, et al.
Pharmaceutics|January 21, 2023
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c TrialJuan Espinosa-Pereiro, Samiksha Ghimire, Marieke G G Sturkenboom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2025
Safety, Efficacy and Pharmacokinetics of daily optimised doses of Rifampicin for the Treatment of Tuberculosis: A Systematic Review and Bayesian Network Meta-AnalysisJuan Espinosa-Pereiro, Ana Aguiar, Eva Nara, et al.
Breathe (Sheffield, England)|November 7, 2022
Non-COVID-19 respiratory viral infectionCláudio Nunes-Silva, Ana Teresa Vilares, Valentijn Schweitzer, et al.
The Pediatric Infectious Disease Journal|August 19, 2025
Pharmacokinetics, Safety, Tolerability and Antiviral Activity of Switching to Oral Rilpivirine in Combination With Other Antiretroviral Therapy in Virologically Suppressed Children Living With HIV-1 Infection: Forty-eight-week Results From the Phase 2, Open-label, Single-arm, PICTURE StudyJohan Lombaard, Francis Ssali, Visal Moolasart, et al.
International Immunopharmacology|October 13, 2025
Resolvin E1-Chemerin receptor 1 axis is dysregulated in critical COVID-19 patientsCarolina Silva-Pereira, Marta Reina-Couto, Patrícia Pereira-Terra, et al.
Biomolecules|May 4, 2026
Annexin A1 and Dexamethasone Treatment in Hospitalized COVID-19 Patients: Impact on Disease Recovery and Evidence for an Interplay Between Proresolving MediatorsCarolina Silva-Pereira, Marta Reina-Couto, Patrícia Pereira-Terra, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 25, 2025
Endocan as a marker of endotheliitis in COVID-19 patients: modulation by veno-venous extracorporeal membrane oxygenation, arterial hypertension and previous treatment with renin-angiotensin-aldosterone system inhibitorsMarta Reina-Couto, David Alves, Carolina Silva-Pereira, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 8, 2023
Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patientsMarta Reina-Couto, Mariana Roboredo-Madeira, Patrícia Pereira-Terra, et al.
Microorganisms|February 5, 2021
Dynamics of a Dual SARS-CoV-2 Lineage Co-Infection on a Prolonged Viral Shedding COVID-19 Case: Insights into Clinical Severity and Disease DurationNicole Pedro, Cláudio N Silva, Ana C Magalhães, et al.
Pageof 5